TY - JOUR
T1 - Recombinant human single-chain MHC-peptide complexes made from E. coli by in vitro refolding
T2 - Functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens
AU - Denkberg, Galit
AU - Cohen, Cyril J.
AU - Segal, Dina
AU - Kirkin, Alexei F.
AU - Reiter, Yoram
PY - 2000
Y1 - 2000
N2 - Soluble recombinant MHC-peptide complexes are valuable tools for molecular characterization of immune responses as well as for other functional and structural studies. In this study, soluble recombinant single-chain human MHC (scMHC)-peptide complexes were generated by in vitro refolding of inclusion bodies from bacterially expressed engineered HLA-A2 in the presence of tumor-associated or viral peptides. The scMHC molecule was composed of β2-microglobulin connected to the first three domains of the HLA-A2 heavy chain through a 15-amino acid flexible linker. Highly purified scMHC-peptide complexes were obtained in high yield using several peptides derived from the melanoma antigens gp100 and MART-1 or a viral peptide derived from HTLV-1. The scMHC complexes were characterized in detail and were found to be correctly folded and able to specifically bind HLA-A2-restricted peptides. We also generated scMHC-peptide tetramers, which were biologically functional; they induced a peptide-specific CTL clone to be activated and secrete IFN-γ, and were able to stain specifically CTL lines. Such recombinant soluble scMHC-peptide complexes and tetramers should prove of great value for characterization of immune responses involving CTL, for visualization of antigen-specific immune responses, for in vitro primary CTL induction, and for peptide binding assays and structural studies.
AB - Soluble recombinant MHC-peptide complexes are valuable tools for molecular characterization of immune responses as well as for other functional and structural studies. In this study, soluble recombinant single-chain human MHC (scMHC)-peptide complexes were generated by in vitro refolding of inclusion bodies from bacterially expressed engineered HLA-A2 in the presence of tumor-associated or viral peptides. The scMHC molecule was composed of β2-microglobulin connected to the first three domains of the HLA-A2 heavy chain through a 15-amino acid flexible linker. Highly purified scMHC-peptide complexes were obtained in high yield using several peptides derived from the melanoma antigens gp100 and MART-1 or a viral peptide derived from HTLV-1. The scMHC complexes were characterized in detail and were found to be correctly folded and able to specifically bind HLA-A2-restricted peptides. We also generated scMHC-peptide tetramers, which were biologically functional; they induced a peptide-specific CTL clone to be activated and secrete IFN-γ, and were able to stain specifically CTL lines. Such recombinant soluble scMHC-peptide complexes and tetramers should prove of great value for characterization of immune responses involving CTL, for visualization of antigen-specific immune responses, for in vitro primary CTL induction, and for peptide binding assays and structural studies.
KW - Cancer peptide
KW - MHC class I
KW - MHC tetramer
UR - http://www.scopus.com/inward/record.url?scp=0034535585&partnerID=8YFLogxK
U2 - 10.1002/1521-4141(2000012)30:12<3522::AID-IMMU3522>3.0.CO;2-D
DO - 10.1002/1521-4141(2000012)30:12<3522::AID-IMMU3522>3.0.CO;2-D
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 11093172
AN - SCOPUS:0034535585
SN - 0014-2980
VL - 30
SP - 3522
EP - 3532
JO - European Journal of Immunology
JF - European Journal of Immunology
IS - 12
ER -